BBP ETF
Virtus LifeSci Biotech Products ETF
BBP ETF Overview
BBP ETF (Virtus LifeSci Biotech Products ETF) is managed by Virtus Investment Partners with $118.1M in net assets. BBP expense ratio is 0.34%, holding 70 positions across sectors including Health Care. Inception date: 2014-12-16.
BBP performance shows a YTD return of 17.73%. The 1-year return is 52.32% and the 5-year return is 13.16%.
BBP top holdings include Moderna therapeutics (3.6%), Omeros Corp Com (2.7%), Iovance Biotherapeutics Inc (2.6%), Verastem Inc (2.4%), Precigen Corp (2.0%). Go to all BBP holdings, BBP sectors, or BBP dividends.
BBP can be compared against other funds. Use BBP overlap to find shared positions, or BBP vs another fund for a side-by-side view. BBP alternatives are available via the screener, along with tax-loss harvesting opportunities.